T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.19 CNY 0.12%
Market Cap: 16B CNY
Have any thoughts about
Tonghua Dongbao Pharmaceutical Co Ltd?
Write Note
Tonghua Dongbao Pharmaceutical Co Ltd
/
Cash Flow Statement
/
Free Cash Flow

Tonghua Dongbao Pharmaceutical Co Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tonghua Dongbao Pharmaceutical Co Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
T
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Free Cash Flow
¥74.5m
CAGR 3-Years
-52%
CAGR 5-Years
-38%
CAGR 10-Years
5%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Free Cash Flow
¥2.9B
CAGR 3-Years
44%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Free Cash Flow
¥1.1B
CAGR 3-Years
52%
CAGR 5-Years
-6%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Free Cash Flow
¥6.3B
CAGR 3-Years
64%
CAGR 5-Years
17%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Free Cash Flow
¥4.4B
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Free Cash Flow
-¥697.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tonghua Dongbao Pharmaceutical Co Ltd
Glance View

Market Cap
16.2B CNY
Industry
Pharmaceuticals

Nestled in the bustling heart of China's pharmaceutical industry, Tonghua Dongbao Pharmaceutical Co., Ltd. has carved out a distinctive niche in the world of diabetes care. Since its inception, the company has been focused on developing, manufacturing, and distributing a range of innovative pharmaceutical products, primarily concentrating on insulin products. With its headquarters strategically located in Tonghua City—a region known for its rich medicinal resources—the company integrates advanced biotechnological processes with traditional pharmaceutical practices. Tonghua Dongbao’s competitive edge lies in its ability to harness cutting-edge technology to produce high-quality insulin products efficiently, allowing it to tap into the rapidly growing domestic and international markets. As diabetes continues to be a major global health challenge, this focus on insulin has positioned the company as a critical player in the fight to manage and treat this chronic disease. Their revenue model is underscored by a keen focus on the production of insulin and its analogs, which represent a significant portion of its sales. Beyond insulin, Tonghua Dongbao also produces a range of other pharmaceuticals, contributing to a diversified product portfolio that supports steady revenue streams. Importantly, the company’s investment in R&D has led to a robust pipeline of new and improved therapeutics aimed at expanding their reach and maintaining competitive advantage. Through strategic partnerships and collaborations, both within China and internationally, Tonghua Dongbao continues to amplify its market presence. In doing so, it exemplifies a commitment not only to financial growth but also to advancing healthcare outcomes for millions of diabetes patients around the globe.

Intrinsic Value
10.09 CNY
Undervaluation 19%
Intrinsic Value
Price
T
What is Intrinsic Value?

See Also

What is Tonghua Dongbao Pharmaceutical Co Ltd's Free Cash Flow?
Free Cash Flow
74.5m CNY

Based on the financial report for Sep 30, 2024, Tonghua Dongbao Pharmaceutical Co Ltd's Free Cash Flow amounts to 74.5m CNY.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
5%

Over the last year, the Free Cash Flow growth was -43%. The average annual Free Cash Flow growth rates for Tonghua Dongbao Pharmaceutical Co Ltd have been -52% over the past three years , -38% over the past five years , and 5% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.